Literature DB >> 27272120

Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals.

D Delle Rose1, P Pezzotti2, E Fortunato3, P Sordillo3, S Gini3, S Boros2, M Meledandri4, M T Gallo5, G Prignano5, R Caccese6, M D'Ambrosio6, G Citterio7, M Rocco7, F Leonardis8, S Natoli8, C Fontana9, M Favaro9, M G Celeste10, T Franci11, G P Testore3, M Andreoni3, L Sarmati3.   

Abstract

The purpose of this study was to assess the main clinical predictors and microbiological features of ventilator-associated pneumonia (VAP) in the Intensive Care Unit (ICU) environment. This work is a retrospective analysis over one year from September 2010 to September 2011. Patients' risk factors, causes of admission, comorbidities and respiratory specimens collected in six Italian ICUs were reviewed. Incidence and case fatality rate of VAP were evaluated. After stratification for VAP development, univariate and multivariate analyses were performed to assess the impact of patients' conditions on the onset of this infection. A total of 1,647 ICU patients (pts) were considered. Overall, 115 patients (6.9 %) experienced at least one episode of VAP. The incidence rate for VAP was 5.82/1,000 pts-days, with a case fatality rate of 44.3 %. Multivariate analysis showed that admission for neurological disorders (aIRR 4.12, CI 1.24-13.68, p = 0.02) and emergency referral to ICU from other hospitals (aIRR 2.11, CI 1.03-4.31, p = 0.04) were associated with higher risk of VAP, whereas a tendency to a higher risk of infection was detected for admission due to respiratory disease, cardiac disease, trauma and for having obesity or renal failure. A total of 372 microbiological isolates from respiratory specimens were collected in VAP patients. The most common species were Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa, showing high resistance rates to carbapenems. Neurological disorders and emergency referral at the admission into the ICU are significantly associated with the onset of VAP. A high incidence of multi-drug resistant Gram- species was detected in the respiratory specimens.

Entities:  

Mesh:

Year:  2016        PMID: 27272120     DOI: 10.1007/s10096-016-2694-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  39 in total

Review 1.  Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management.

Authors:  Alberto Sandiumenge; Jordi Rello
Journal:  Curr Opin Pulm Med       Date:  2012-05       Impact factor: 3.155

Review 2.  Ventilator-associated pneumonia: current status and future recommendations.

Authors:  Shai Efrati; Israel Deutsch; Massimo Antonelli; Peter M Hockey; Ronen Rozenblum; Gabriel M Gurman
Journal:  J Clin Monit Comput       Date:  2010-03-17       Impact factor: 2.502

3.  Risk of misleading ventilator-associated pneumonia rates with use of standard clinical and microbiological criteria.

Authors:  Michael Klompas; Martin Kulldorff; Richard Platt
Journal:  Clin Infect Dis       Date:  2008-05-01       Impact factor: 9.079

4.  Risk factors for ventilator-associated pneumonia: among trauma patients with and without brain injury.

Authors:  Anastasia Gianakis; Molly McNett; Josie Belle; Cristina Moran; Dawn Grimm
Journal:  J Trauma Nurs       Date:  2015 May-Jun       Impact factor: 1.010

Review 5.  Ventilator-associated pneumonia.

Authors:  Jean Chastre; Jean-Yves Fagon
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

6.  Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.

Authors:  Chris M Parker; Jim Kutsogiannis; John Muscedere; Deborah Cook; Peter Dodek; Andrew G Day; Daren K Heyland
Journal:  J Crit Care       Date:  2008-03       Impact factor: 3.425

7.  Nosocomial ventilator-associated pneumonia in Cuban intensive care units: bacterial species and antibiotic resistance.

Authors:  Manuel Medell; Marcia Hart; Amílcar Duquesne; Fidel Espinosa; Rodolfo Valdés
Journal:  MEDICC Rev       Date:  2013-04       Impact factor: 0.583

8.  Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units.

Authors:  Marta M Wroblewska; Jolanta Rudnicka; Halina Marchel; Miroslaw Luczak
Journal:  Int J Antimicrob Agents       Date:  2006-03-20       Impact factor: 5.283

9.  Candida spp. airway colonization: A potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia.

Authors:  Xiaojiang Tan; Song Zhu; Dongxing Yan; Weiping Chen; Ruilan Chen; Jian Zou; Jingdong Yan; Xiangdong Zhang; Dimitrios Farmakiotis; Eleftherios Mylonakis
Journal:  Med Mycol       Date:  2016-03-21       Impact factor: 4.076

10.  A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study.

Authors:  Andrew A Quartin; Ernesto G Scerpella; Sailaja Puttagunta; Daniel H Kett
Journal:  BMC Infect Dis       Date:  2013-11-27       Impact factor: 3.090

View more
  4 in total

Review 1.  Resistance Trends and Treatment Options in Gram-Negative Ventilator-Associated Pneumonia.

Authors:  Nathaniel J Rhodes; Caroline E Cruce; J Nicholas O'Donnell; Richard G Wunderink; Alan R Hauser
Journal:  Curr Infect Dis Rep       Date:  2018-03-06       Impact factor: 3.725

2.  Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial.

Authors:  José M Cisneros; Clara María Rosso-Fernández; Cristina Roca-Oporto; Gennaro De Pascale; Silvia Jiménez-Jorge; Esteban Fernández-Hinojosa; Dimitrios K Matthaiou; Paula Ramírez; Ramón Ortiz Díaz-Miguel; Angel Estella; Massimo Antonelli; George Dimopoulos; José Garnacho-Montero
Journal:  Crit Care       Date:  2019-11-28       Impact factor: 9.097

3.  Identification and detection of pathogenic bacteria from patients with hospital-acquired pneumonia in southwestern Iran; evaluation of biofilm production and molecular typing of bacterial isolates.

Authors:  Farzad Mazloomirad; Sajad Hasanzadeh; Asghar Sharifi; Gordafarin Nikbakht; Narges Roustaei; Seyed Sajjad Khoramrooz
Journal:  BMC Pulm Med       Date:  2021-12-09       Impact factor: 3.317

4.  Clinical outcome of nosocomial pneumonia caused by Carbapenem-resistant gram-negative bacteria in critically ill patients: a multicenter retrospective observational study.

Authors:  Chih-Yu Chen; Kuang-Yao Yang; Chung-Kan Peng; Chau-Chyun Sheu; Ming-Cheng Chan; Jia-Yih Feng; Sheng-Huei Wang; Chia-Min Chen; Zhe-Rong Zheng; Shinn-Jye Liang; Yu-Chao Lin
Journal:  Sci Rep       Date:  2022-05-07       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.